Drug maker Concordia in talks to sell equity stake: sources

(Reuters) - Concordia International Corp , a Canadian specialty pharmaceutical company, is discussing alternatives to a leveraged buyout that include divesting a minority stake to a private equity firm, people familiar with the matter said on Monday.